References
F.X. Yu, B. Zhao, K.L. Guan, Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell 163(4), 811–828 (2015)
K.F. Harvey, X. Zhang, D.M. Thomas, The hippo pathway and human cancer. Nat. Rev. Cancer 13, 246–257 (2013)
A.A. Steinhardt, M.F. Gayyed, A.P. Klein, J. Dong, A. Maitra, D. Pan, E.A. Montgomery, R.A. Anders, Expression of Yes-associated protein in common solid tumors. Hum. Pathol. 39, 1582–1589 (2008)
L. Guo, L. Teng, YAP/TAZ for cancer therapy: opportunities and challenge. Int. J. Oncol. 46, 1444–1452 (2015)
S.E. Lee, J.U. Lee, M.H. Lee, M.J. Ryu, S.J. Kim, Y.K. Kim, M.J. Choi, K.S. Kim, J.M. Kim, J.W. Kim, Y.W. Koh, D.S. Lim, Y.S. Jo, M. Shong, RAF kinase inhibitor-independent constitutive activation of Yes-associated protein 1 promotes tumor progression in thyroid cancer. Oncogenesis 2, e55 (2013)
M.E. Garcia-Rendueles, J.C. Ricarte-Filho, B.R. Untch, I. Landa, J.A. Knauf, F. Voza, V.E. Smith, I. Ganly, B.S. Taylor, Y. Persaud, G. Oler, Y. Fang, S.C. Jhanwar, A. Viale, A. Heguy, K.H. Huberman, F. Giancotti, R. Ghossein, J.A. Fagin, NF2 loss promotes oncogenic RAS-induced thyroid cancers via YAP-dependent transactivation of RAS proteins and sensitizes them to MEK inhibition. Cancer Discov. 5(11), 1178–1193 (2015)
B.R. Haugen, E.K. Alexander, K.C. Bible, G. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G. Randolph, A. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D. Steward, R.M. Tuttle, L. Wartofsky, 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1–133 (2016)
M. Sponziello, C. Durante, A. Boichard, M. Dima, C. Puppin, A. Verrienti, G. Tamburrano, G. Di Rocco, A. Redler, L. Lacroix, J.M. Bidart, M. Schlumberger, G. Damante, D. Russo, S. Filetti, Epigenetic-related gene expression profile in medullary thyroid cancer revealed the overexpression of the histone methyltransferases EZH2 and SMYD3 in aggressive tumours. Mol. Cell. Endocrinol. 392, 8–13 (2014)
C. Mignogna, N. Staropoli, C. Botta, C. De Marco, A. Rizzuto, M. Morelli, A. Di Cello, R. Franco, C. Camastra, I. Presta, N. Malara, A. Salvino, P. Tassone, P. Tagliaferri, T. Barni, G. Donato, A. Di Vito, Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients. J. Ovarian Res. 9(1), 31 (2016)
M. Sponziello, A. Verrienti, F. Rosignolo, R.F. De Rose, V. Pecce, V. Maggisano, C. Durante, S. Bulotta, G. Damante, L. Giacomelli, C.R. Di Gioia, S. Filetti, D. Russo, M. Celano, PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells. Endocrine 50(2), 434–441 (2015)
M. Schlumberger, L. Lacroix, D. Russo, S. Filetti, J.M. Bidart, Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patients. Nat. Clin. Pract. Endocrinol. Metab. 3, 260–269 (2007)
M.E. Cabanillas, D.G. McFaddek, C. Durante, Thyroid Cancer. Lancet 388, 2783–2795 (2016)
S. Jin, O. Borkhuu, W. Bao, Y.T. Yang, Signaling pathways in thyroid cancer and their therapeutic implications. J. Clin. Med. Res. 8(4), 284–296 (2016)
S. Bulotta, M. Celano, G. Costante, D. Russo, Emerging strategies for managing differentiated thyroid cancers refractory to radioiodine. Endocrine 52, 214–221 (2016)
R. Abylkassov, Y. Xie, Role of yes-associated protein in cancer: An update. Oncol. Lett. 12(4), 2277–2282 (2016)
M. Yuan, V. Tomlison, R. Lara, D. Holliday, C. Chelala, T. Harada, R. Gangeswaran, C. Manson-Bishop, P. Smith, S.A. Danovi, O. Pardo, T. Crook, C.A. Mein, N.R. Lemoine, L.J. Jones, S. Basu, Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell. Death Differ. 15, 1752–1759 (2008)
C. Ugolini, N. Borrelli, C. Niccoli, R. Elisei, D. Viola, P. Vitti, P. Miccoli, F. Basolo, Role of YAP-1 in thyroid tumor progression and outcome. Appl. Immunohistochem. Mol. Morphol. [epub ahead of print] Oct 7 (2016)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Celano, M., Mignogna, C., Rosignolo, F. et al. Expression of YAP1 in aggressive thyroid cancer. Endocrine 59, 209–212 (2018). https://doi.org/10.1007/s12020-017-1240-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-017-1240-6